A Proton-Coupled Transport System for β-Hydroxy-β-Methylbutyrate (HMB) in Blood–Brain Barrier Endothelial Cell Line hCMEC/D3
Open Access
- 16 September 2021
- Vol. 13 (9) , 3220
Abstract
β-Hydroxy-β-methylbutyrate (HMB), a leucine metabolite, is used as a nutritional ingredient to improve skeletal muscle health. Preclinical studies indicate that this supplement also elicits significant benefits in the brain; it promotes neurite outgrowth and prevents age-related reductions in neuronal dendrites and cognitive performance. As orally administered HMB elicits these effects in the brain, we infer that HMB crosses the blood–brain barrier (BBB). However, there have been no reports detailing the transport mechanism for HMB in BBB. Here we show that HMB is taken up in the human BBB endothelial cell line hCMEC/D3 via H+-coupled monocarboxylate transporters that also transport lactate and β-hydroxybutyrate. MCT1 (monocarboxylate transporter 1) and MCT4 (monocarboxylate transporter 4) belonging to the solute carrier gene family SLC16 (solute carrier, gene family 16) are involved, but additional transporters also contribute to the process. HMB uptake in BBB endothelial cells results in intracellular acidification, demonstrating cotransport with H+. Since HMB is known to activate mTOR with potential to elicit transcriptomic changes, we examined the influence of HMB on the expression of selective transporters. We found no change in MCT1 and MCT4 expression. Interestingly, the expression of LAT1 (system L amino acid transporter 1), a high-affinity transporter for branched-chain amino acids relevant to neurological disorders such as autism, is induced. This effect is dependent on mTOR (mechanistic target of rapamycine) activation by HMB with no involvement of histone deacetylases. These studies show that HMB in systemic circulation can cross the BBB via carrier-mediated processes, and that it also has a positive influence on the expression of LAT1, an important amino acid transporter in the BBB.Keywords
Funding Information
- Welch Foundation (BI-0028)
This publication has 44 references indexed in Scilit:
- A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fastingGenes & Development, 2012
- The SLC36 family of proton‐coupled amino acid transporters and their potential role in drug transportBritish Journal of Pharmacology, 2011
- β-Hydroxy-β-methylbutyrate (HMβ) supplementation stimulates skeletal muscle hypertrophy in rats via the mTOR pathwayNutrition & Metabolism, 2011
- Blockade of Dendritic Cell Development by Bacterial Fermentation Products Butyrate and Propionate through a Transporter (Slc5a8)-dependent Inhibition of Histone DeacetylasesJournal of Biological Chemistry, 2010
- Subcellular localization of transporters along the rat blood–brain barrier and blood–cerebral-spinal fluid barrier by in vivo biotinylationNeuroscience, 2008
- Vacuolar-type H+-ATPases at the plasma membrane regulate pH and cell migration in microvascular endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Blood‐brain barrier‐specific properties of a human adult brain endothelial cell lineThe FASEB Journal, 2005
- A novel bifunctionality: PAT1 and PAT2 mediate electrogenic proton/amino acid and electroneutral proton/fatty acid symportThe FASEB Journal, 2004
- Transport and uptake of nateglinide in Caco‐2 cells and its inhibitory effect on human monocarboxylate transporter MCT1British Journal of Pharmacology, 2002
- Identification of a Unique Monocarboxylate Transporter (MCT3) in Retinal Pigment EpitheliumBiochemical and Biophysical Research Communications, 1997